Logo image of NHC

NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:NHC - US6359061008 - Common Stock

144.95 USD
+1.16 (+0.81%)
Last: 1/22/2026, 8:04:00 PM
144.95 USD
0 (0%)
After Hours: 1/22/2026, 8:04:00 PM
Fundamental Rating

6

NHC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While NHC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NHC is valued correctly, but it does not seem to be growing. NHC also has an excellent dividend rating. These ratings could make NHC a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • NHC had positive earnings in the past year.
  • NHC had a positive operating cash flow in the past year.
  • NHC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years NHC had a positive operating cash flow.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • NHC has a better Return On Assets (6.71%) than 87.25% of its industry peers.
  • NHC has a Return On Equity of 10.26%. This is in the better half of the industry: NHC outperforms 74.51% of its industry peers.
  • NHC has a Return On Invested Capital of 6.69%. This is in the better half of the industry: NHC outperforms 65.69% of its industry peers.
  • NHC had an Average Return On Invested Capital over the past 3 years of 3.68%. This is significantly below the industry average of 9.21%.
  • The last Return On Invested Capital (6.69%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROIC 6.69%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • NHC's Profit Margin of 7.19% is amongst the best of the industry. NHC outperforms 87.25% of its industry peers.
  • NHC's Profit Margin has improved in the last couple of years.
  • NHC has a Operating Margin of 7.99%. This is in the better half of the industry: NHC outperforms 75.49% of its industry peers.
  • In the last couple of years the Operating Margin of NHC has grown nicely.
  • NHC has a better Gross Margin (38.11%) than 67.65% of its industry peers.
  • NHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
  • The number of shares outstanding for NHC has been increased compared to 1 year ago.
  • Compared to 5 years ago, NHC has more shares outstanding
  • The debt/assets ratio for NHC is higher compared to a year ago.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.51 indicates that NHC is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.51, NHC belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
  • NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.93, NHC belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that NHC is not too dependend on debt financing.
  • The Debt to Equity ratio of NHC (0.10) is better than 75.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Altman-Z 4.51
ROIC/WACC0.75
WACC8.87%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
  • The Current ratio of NHC (1.72) is better than 69.61% of its industry peers.
  • A Quick Ratio of 1.69 indicates that NHC should not have too much problems paying its short term obligations.
  • NHC's Quick ratio of 1.69 is fine compared to the rest of the industry. NHC outperforms 71.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.69
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • NHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.19%, which is quite good.
  • NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
  • The Revenue has grown by 22.82% in the past year. This is a very strong growth!
  • NHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.60, NHC is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 69.61% of the companies listed in the same industry.
  • NHC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.6
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NHC is cheaper than 66.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 69.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.92
EV/EBITDA 12.06
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.69
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

  • NHC has a Yearly Dividend Yield of 1.84%.
  • NHC's Dividend Yield is rather good when compared to the industry average which is at 0.59. NHC pays more dividend than 92.16% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, NHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.84%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.30%.
  • NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 35.96% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (1/22/2026, 8:04:00 PM)

After market: 144.95 0 (0%)

144.95

+1.16 (+0.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31
Earnings (Next)02-25
Inst Owners62.44%
Inst Owner Change0.14%
Ins Owners7.07%
Ins Owner Change-0.09%
Market Cap2.25B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %3.32%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield 1.84%
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE N/A
P/S 1.54
P/FCF 18.92
P/OCF 15.09
P/B 2.2
P/tB 2.71
EV/EBITDA 12.06
EPS(TTM)6.71
EY4.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.29%
OCF(TTM)9.61
OCFY6.63%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.69
Graham Number99.7
Profitability
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROCE 9.01%
ROIC 6.69%
ROICexc 8.35%
ROICexgc 10.23%
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
FCFM 8.16%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Debt/EBITDA 0.64
Cap/Depr 68.45%
Cap/Sales 2.07%
Interest Coverage 250
Cash Conversion 92.81%
Profit Quality 113.47%
Current Ratio 1.72
Quick Ratio 1.69
Altman-Z 4.51
F-Score4
WACC8.87%
ROIC/WACC0.75
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%

NATIONAL HEALTHCARE CORP / NHC FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.